Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 23, 2026 08:00 ET | Source: Alps Group Inc

Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol

KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated...
February 19, 2026 10:08 ET | Source: Research and Markets

4 Day Virtual UK Payroll Training Course: Payroll Calculations, Tax Codes, Statutory Payments, and Auto-enrolment (April 13-16, 2026)

Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Payroll Training (April 13-16, 2026)" training has been added to ResearchAndMarkets.com's offering. Effective payroll management is vital for...
February 19, 2026 09:51 ET | Source: Research and Markets

2 Day Online Sage Payroll Training Course: Hands-on Practice, Expert-led Instruction, and Future-proof Skills (April 15-16, 2026)

Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Sage Payroll Training (April 15-16, 2026)" training has been added to ResearchAndMarkets.com's offering. Master the essentials of payroll...
February 17, 2026 09:25 ET | Source: Critical Metals Corp

Critical Metals Corp. Proudly Announces the Highest Re-Assay TREO Results From Inception From (33) Drill Holes Results

NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, today announced our strongest...
February 17, 2026 08:30 ET | Source: BioMedWire

Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A

AUSTIN, Texas, Feb. 17, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Biotech dealmaking is increasingly defined by a clear strategic shift: Pharmaceutical companies are prioritizing...
February 11, 2026 11:59 ET | Source: SageX AI

SageX Launches Unstructured Data Platform for AI Data Transformation - Emerges As The Infrastructure Layer Powering Reliable Enterprise AI Systems

NEW YORK, NY, Feb. 11, 2026 (GLOBE NEWSWIRE) -- NEW YORK, NY - February 11, 2026 - - SageX, an AI-native enterprise data platform, today announced its position as the platform solving one of...
February 11, 2026 08:07 ET | Source: Helus Pharma

Helus Pharma nombra a Michael Cola como director ejecutivo para liderar su próxima etapa de crecimiento y ejecución

Ex presidente de la división de farmacéutica especializada de Shire PLC (“Shire”), con más de 30 años de experiencia en neurociencia, enfermedades raras y productos farmacéuticos especializados,...
February 11, 2026 08:07 ET | Source: Helus Pharma

ヘラス・ファーマ、次段階の規模拡大と事業実行主導に向けてマイケル・コーラを最高経営責任者に任命

シャイアーPLC (Shire PLC) (以下「シャイアー」) スペシャリティ医薬品事業部門の元社長であり、アストラ・メルク (Astra-Merck) およびアストラゼネカ (AstraZeneca PLC) でも上級管理職を務め、神経科学、希少疾患、スペシャリティ医薬品分野において30年以上の経験中枢神経系 (以下「CNS」)...
February 11, 2026 08:07 ET | Source: Helus Pharma

Helus Pharma nomme Michael Cola au poste de directeur général pour piloter la prochaine phase de développement et d’exécution

Ancien président de la division pharmaceutique spécialisée de Shire PLC (« Shire »), il cumule plus de 30 ans d’expérience dans les domaines des neurosciences, des maladies rares et des produits...
February 11, 2026 08:07 ET | Source: Helus Pharma

Helus Pharma 任命 Michael Cola 出任首席执行官，带领公司迈入规模化发展与战略执行新阶段

他曾任 Shire PLC (“Shire”) 特殊药品业务部前总裁，拥有超过 30 年涵盖神经科学、罕见疾病及特殊药品领域的丰富经验，并曾在 Astra-Merck 与 AstraZeneca PLC 担任高管职务作为领导者，他在中枢神经系统 (“CNS”) 领域项目中，于晚期临床研发、全球商业化及资本筹集方面拥有公认的成功经验此次任命正值 Helus Pharma...